Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Acta Endocrinol (Buchar) ; 19(2): 221-227, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37908888

RESUMO

Introduction: Antioxidants and unsaturated fatty acids have protective effects in obesity. Aim: We investigated the benefits of Omega-3 fatty acids associated with antioxidant vitamins in obese children. Magnesemia and calcemia were observed in relation with other metabolic parameters, before and after the treatment. Materials and methods: 60 obese children were compared with 35 normal weight children. Each obese child received daily, one pill, containing: 130mg docosahexaenoic acid, 25mg of eicosapentaenoic acid, vitamin A 200µg, vitamin D 1,25µg, vitamin E 2,5mg and vitamin C 30mg for three months. All the participants were instructed not to change their lifestyle. Results: The serum values for these minerals and for 25(OH) vitamin D were lower in obese children. The obese children had insulin resistance (HOMA-IR) and an imbalance of serum adipocytokines. In obese children, the body mass index was negatively correlated with calcemia (r=-0.34) and serum 25(OH) vitamin D (r=-0.33). The HOMA-IR was negatively correlated with magnesemia (r=-0.34) and serum adiponectin (r=-0.29). The treatment improved the mineral serum level, the insulin sensitivity and the adipocytokines levels. Conclusion: In obese children, the intake of Omega-3 fatty acids associated with antioxidant vitamins, for three months improved calcemia and magnesemia and increased insulin sensitivity.

2.
Acta Endocrinol (Buchar) ; 18(4): 488-493, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-37152869

RESUMO

Introduction: Vitamin D is involved in differentiation and induction of erythropoiesis in bone marrow cells. Aim: We compared the serum 25(OH) vitamin D level in obese children versus control and found correlations between vitamin D level and hematological indices in obese children. Materials and methods: 25 overweight and obese patients and 15 normal weight children were enrolled in an observational study . Results: In obese children, the serum level of 25(OH) vitamin D was significantly (p<0.04) lower (20.60 ng/mL) compared with the value from normal weight ones (25.63 ng/mL) and the body fat percentage BFP was higher. We found a positive correlation (r=0.44, p<0.05) between serum vitamin D and hemoglobin level and a negative one between serum vitamin D and the number of platelets (r= -0.43, p<0.05). Also, the serum iron was at the lower normal limit in the obese children and negatively correlated with the percent of the body fat (r= -0,62, p<0.05). Conclusion: Obese children have vitamin D deficiency. The hemoglobin level and the number of platelets are correlated with the serum level of 25(OH) vitamin D. Supplements with vitamin D may have pleiotropic effects, including those on bone marrow activity.

3.
Acta Endocrinol (Buchar) ; 12(4): 407-412, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-31149123

RESUMO

CONTEXT: Adipokines secreted by fat cells are vital to the control of energy metabolism, communicating the nutrient status with the tissues responsible for controlling both energy intake and expenditure and insulin sensitivity. OBJECTIVE: We aimed to prove in an experimental animal study that maternal obesity has long term adverse fetal metabolic consequences, which pass on even to the next generation of descendants. DESIGN: The effects of maternal obesity have been studied on animal model using 50 obese female Wistar rats, in which we induced obesity by high-calorie high-fat diet administered by gavage. SUBJECTS AND METHODS: Obese rat females were sacrificed at gestation term and we analyzed the secretion of adipokines from maternal venous blood: leptin and adiponectin, placental, pancreatic, liver and brain homogenates lipid peroxidation levels estimated by: MDA (malonyl-dialdehyde), total thiols and GSH - as antioxidant factors and routine biochemistry. RESULTS: Low levels of adiponectin and increased levels of leptin positively correlated with the value of placental and fetal tissue lipid peroxidation (from the liver, pancreas and brain) measured by elevated MDA and total thiols and low levels of GSH. The lipid peroxidation in the organs examined generated consistent results, showing high levels of peroxidation expressed through high values of MDA in the groups with Omega 6 supplements respectively no supplementation, and low levels of antioxidants expressed through glutathione and thiols. CONCLUSIONS: Endocrine secretion of adipokines from the adipocytes and the recruited macrophages of obese mothers is positively correlated with placental and tissue lipid peroxidation level and routine biochemical parameters.

4.
Biotech Histochem ; 90(7): 552-8, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25839238

RESUMO

There are few reports concerning the potential for clinical application of oxidative stress (OS) and collagen degradation markers in oral lichen planus (OLP) patients. We investigated the possibility of using some disease-related biomarkers in saliva and serum of OLP patients. Our study included 30 patients with OLP and 30 controls. We evaluated serum and salivary OS biomarkers including 8-OHdG, MDA, uric acid, TAC and GPx. We also investigated collagen degradation markers such as CTX I and MMP-8. We found significantly increased salivary levels of MMP-8 and CTX I in the OLP group compared to controls and significant differences between the OLP and control groups in serum and saliva for 8-OHdG, MDA (significantly increased), uric acid, TAC and GPx (significantly reduced). Currently there are no criteria for evaluating which OLP patients have a greater risk of malignant transformation. In addition to clinical surveillance, the serum and salivary biomarkers that we evaluated may be useful biomarkers for monitoring OLP patients in the future.


Assuntos
Líquen Plano Bucal/diagnóstico , Neoplasias Bucais/diagnóstico , Saliva/metabolismo , Adolescente , Adulto , Idoso , Biomarcadores/análise , Biomarcadores/metabolismo , Feminino , Humanos , Inflamação/diagnóstico , Líquen Plano Bucal/sangue , Masculino , Pessoa de Meia-Idade , Neoplasias Bucais/metabolismo , Estresse Oxidativo , Adulto Jovem
5.
Biofactors ; 33(4): 301-10, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-19509465

RESUMO

Oral lichen planus (OLP) is a relatively common disorder whose cause is still unknown. Oral cancer is preceded in most cases by pre malignant lesions-leukoplasia, submucous fibrosis and lichen planus. Free radicals and reactive oxygen species play important roles in both pathogenesis of lichen planus and carcinogenesis. Thus monitoring systemic and saliva compounds important for the antioxidant defence (oxidative balance) could be important for the clinician's treatment strategy. Thorough medical management and early active treatment are necessary to improve symptoms and might also be a relevant prevention strategy from squamous cell carcinoma risk, although data to fully support this statement still need investigation. The principal aim of this study was to determine the systemic uric acid, GGT, and albumin levels as well as the levels of uric acid and albumin in 20 patients diagnosed with lichen planus and 20 controls. Extensive medline search failed to reveal any study of this type. Our results showed a significant decrease of saliva (p < 0.005) uric acid and an increase in serum gamma glutamyl transpherase (GGT) (p < 0.01) as well as in the total antioxidant capacity of saliva in patient group with respect to the control one. The preliminary conclusion of our study is that uric acid, the most important salivary antioxidant and GGT could be considered in the future as useful markers of oxidative stress for elaboration of treatment strategy and monitoring.


Assuntos
Biomarcadores/metabolismo , Líquen Plano Bucal/metabolismo , Estresse Oxidativo , Adolescente , Adulto , Idoso , Antioxidantes/metabolismo , Humanos , Pessoa de Meia-Idade , Saliva/metabolismo , Albumina Sérica/metabolismo , Ácido Úrico/metabolismo , gama-Glutamiltransferase/sangue
6.
Rom J Intern Med ; 38-39: 33-50, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-15529570

RESUMO

This paper is a brief overview of current knowledge about DT-diaphorase [NAD(P)H: Quinone Oxidoreductase, NQO], flavoprotein that catalyzes the obligatory two-electron reduction of a wide variety of substrates. The most efficient substrates are quinones but the enzyme will also reduce quinone-imines, nitro and azo compounds. NQO is unique among known NAD(P)H-oxidizing flavoproteins in being a 2-electron transferring quinone reductase, and play a major role in preventing one-electron reduction of exogenous quinones by other enzymes to auto-oxidable semiquinones and concomitant superoxide-radical generation. Induction of NQO by a variety of xenobiotics (potential sources of free-radical formation which lead to DNA and cell damage) provides protection from the cytotoxic and carcinogenic effects of these compounds. NQO has an important role in the bioreductive activation of various quinones used in cancer chemotherapy.


Assuntos
NAD(P)H Desidrogenase (Quinona)/farmacologia , Animais , Expressão Gênica , Humanos , Inativação Metabólica , NAD(P)H Desidrogenase (Quinona)/genética , NAD(P)H Desidrogenase (Quinona)/metabolismo , NAD(P)H Desidrogenase (Quinona)/farmacocinética , Oxirredução/efeitos dos fármacos , Relação Estrutura-Atividade , Especificidade por Substrato
7.
Rom J Intern Med ; 37(1): 3-14, 1999.
Artigo em Inglês | MEDLINE | ID: mdl-15523940

RESUMO

This article is a brief review of current knowledge concerning some basic concepts about the redox and addition chemistry of quinones, followd by a survey of current information regarding the biochemistry of quinones in mammalian cells and their pro- and antioxidant functions. In recent years it has been recognized that ubiquinone (Coenzyme Q), in addition to its involvement as an electron and proton carrier in mitochondrial and bacterial respiration, acts in its reduced form (ubiquinol) as an antioxidant. The antioxidant activity, together with its high degree of hydrophobicity and its widespread occurrence in biological membranes and in low-density lipoprotein, suggest un important role of ubiquinol in cellular defense against oxidative damage. Degenerative diseases and aging may be manifestations of a decreased capacity to maintain adequate ubiquinol levels.


Assuntos
Antioxidantes , Ubiquinona , Ubiquinona/análogos & derivados , Animais , Antioxidantes/química , Antioxidantes/metabolismo , Humanos , Peroxidação de Lipídeos , Mamíferos , Oxirredução , Ubiquinona/química , Ubiquinona/farmacocinética , Ubiquinona/farmacologia , Ubiquinona/fisiologia
8.
Rom J Intern Med ; 36(1-2): 105-11, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-10660975

RESUMO

The aim of the study was to test the fluticasone propionate (FP) efficacy in the treatment of patients with bronchial asthma (BA), not controlled by high doses (more than 1 mg) of other inhaled corticosteroids. Asthma symptoms (degree of dyspnea on Sadoul scale, percentage of symptom-free days and nights), and drug consumption were measured and lung function tests were performed in 20 patients (11 women and 9 men, mean age 47 years) for a 2 months period. Biochemical measurements were done referring to oxidant/antioxidant imbalance, which is characteristic to inflammatory diseases of respiratory system. We evaluated lipoperoxidation (LPO) in the plasma and the blood, before and after FP treatment, by determining malondialdehyde (MDA) status, superoxide-dismutase and ceruloplasmine activity and non-protein SH groups (essential glutathione) status. The biochemical measurements showed a significant decrease in lipid peroxides level in the plasma and the blood and a slight increase of glutathione after 2 months treatment with FP. Lung function tests were performed on a Flow Streen Jaeger and we determined: peak expiratory flow (PEF), vital capacity (VC), forced expiratory volume in 1 sec. (FEV1) and mid-expiratory flow at 50% VC (MEF50). The measurements were done before FP administration, after 3 days, 7 days, 1 month and 2 months. The dose of FP was equivalent to 50-75% of the daily dose of Beclomethasone dipropionate (BD) previously administered. The degree of dyspnea diminished from 3-4 to 0-1. The percentage of symptom-free days and nights improved from 12% to 78% and 25% to 95% respectively. The use of short acting beta agonists diminished with 75% and no patients required i.v. corticotherapy or theophylline. PEF increased with a mean of 25%, VC with a mean of 23%, FEV1 with a mean of 30% and MEF50 with a mean of 36%. Our results demonstrate improved efficacy of FP vs high doses of other inhaled corticosteroids in the treatment of moderate persistent and severe forms of BA.


Assuntos
Corticosteroides/administração & dosagem , Androstadienos/administração & dosagem , Antiasmáticos/administração & dosagem , Asma/tratamento farmacológico , Administração por Inalação , Asma/sangue , Asma/fisiopatologia , Feminino , Fluticasona , Humanos , Masculino , Pessoa de Meia-Idade , Testes de Função Respiratória/estatística & dados numéricos
9.
Rom J Intern Med ; 35(1-4): 89-98, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9562658

RESUMO

Free radical oxidation--peroxidation products, superoxide dismutase (SOD) activity--and nonproteic thiols were measured in blood from 10 normal subjects and 10 patients with rheumatoid arthritis (RA). Peroxidation products and SOD activity have been found significantly elevated, while blood nonproteic thiols have been found significantly lower in RA patients, as compared to normal controls. Also, plasmatic concentration of ceruloplasmin has been found significantly higher in RA patients than in controls.


Assuntos
Artrite Reumatoide/sangue , Espécies Reativas de Oxigênio/metabolismo , Adulto , Ceruloplasmina/análise , Feminino , Radicais Livres/sangue , Humanos , Peroxidação de Lipídeos , Masculino , Pessoa de Meia-Idade , Compostos de Sulfidrila/sangue , Superóxido Dismutase/sangue , Veias
10.
Rom J Intern Med ; 33(3-4): 237-42, 1995.
Artigo em Inglês | MEDLINE | ID: mdl-8646196

RESUMO

Plasma and blood lipid peroxidation, activity of erythrocyte superoxide dismutase (SOD), and serum antioxidant activity (AOA) in uremic patients were examined before and 15 and 30 minutes after the start of dialysis. Hemodialysis was found to produce increased lipid peroxidation in plasma and blood and a simultaneous decrease of SOD activity. The extracellular antioxidant systems were evaluated by the assay of ceruloplasmin level, which did not modify significantly during the dialysis. Our data indicate that the time since the start of dialysis is an important, but not unique factor, influencing possible oxidative damage during hemodialysis.


Assuntos
Antioxidantes , Falência Renal Crônica/sangue , Falência Renal Crônica/terapia , Peroxidação de Lipídeos , Diálise Renal , Adulto , Idoso , Biomarcadores/sangue , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Tempo , Uremia/sangue , Uremia/terapia
11.
Rev Roum Physiol (1990) ; 28(3-4): 133-7, 1991.
Artigo em Inglês | MEDLINE | ID: mdl-1823582

RESUMO

A single dose of ethanol to rats (6 g ethanol/kg body weight) resulted in an increase of lipid-peroxidation in brain, a decrease of anti oxidant enzyme activity in blood serum and alteration in red cell membrane permeability, possibly in an excess of oxygen derived free radicals and physical interaction with membranes.


Assuntos
Intoxicação Alcoólica/metabolismo , Encéfalo/efeitos dos fármacos , Etanol/toxicidade , Peroxidação de Lipídeos/efeitos dos fármacos , Intoxicação Alcoólica/sangue , Animais , Encéfalo/metabolismo , Membrana Eritrocítica/efeitos dos fármacos , Masculino , Oxirredução , Ratos , Ratos Endogâmicos
12.
Rev Roum Physiol (1990) ; 27(1): 15-20, 1990.
Artigo em Inglês | MEDLINE | ID: mdl-2094341

RESUMO

The authors performed another controlled trial in 33 top swimmers (16 girls and 17 boys) in order to make evident some acute and chronic effects (antioxidant) of selenium. Lipid peroxides (MDA-malondialdehyde), nonproteic--SH (essential glutathione) in the serum and blood lactate had been recorded initially on basal conditions and after 2 h endurance training (swimming) accompanied by a per oral administration of 150 micrograms selenium (respectively placebo); one week later we applied the cross-over method. In another trial we continued the treatment with 100 micrograms selenium daily for 14 days (n = 9), respectively placebo (n = 7) and then we applied the crossover method for another 14 days. The above biochemical parameters were recorded initially at rest, under basal conditions, after 14 days of treatment and again after 14 days of treatment, when crossing-over. No significant changes were noticed after a single dose + 2 h hard training, both under selenium and placebo treatment and also when the cross-over method was applied. Fourteen days of selenium treatment induced significant changes of lipid peroxides (especially when the subjects came after placebo) and nonproteic--SH, compared to placebo, changes which support the idea of some antioxidant effects of selenium which might be useful in endurance athletes.


Assuntos
Antioxidantes , Exercício Físico/fisiologia , Resistência Física/fisiologia , Selênio/farmacologia , Natação , Administração Oral , Adolescente , Adulto , Método Duplo-Cego , Feminino , Glutationa/sangue , Humanos , Lactatos/sangue , Masculino , Peróxidos/sangue , Resistência Física/efeitos dos fármacos , Selênio/administração & dosagem
13.
Physiologie ; 25(4): 187-90, 1988.
Artigo em Inglês | MEDLINE | ID: mdl-3148941

RESUMO

The authors performed a controlled trial in 18 top athletes (9 weight lifters and 9 rowers, girls) in order to make evident some chronic and acute effects (antioxidant) of selenium. Nonprotein--SH (essential glutathione), lipid peroxides (MDA-malondialdehyde), glucose-6-phosphate dehydrogenases (G-6-PDH) and fructose-1,6-diphosphate aldolase in serum, have been recorded initially on basal conditions, after 3 weeks of treatment (100 micrograms/day selenium or placebo) and again after 3 weeks of treatment, also on basal conditions, when crossing over the groups (between a free interval of 10 days). In another trial we registered these parameters on basal conditions and after two hours of hard training accompanied by a per oral administration of 150 micrograms selenium (respectively placebo). The results show significant changes under selenium treatment of the peroxides, G-6-PDH and light changes, not significant of the nonprotein--SH, changes which could suggest an antioxidant effect of this element.


Assuntos
Selênio/uso terapêutico , Esportes , Adolescente , Adulto , Ensaios Clínicos como Assunto , Feminino , Frutose-Bifosfato Aldolase/sangue , Glucosefosfato Desidrogenase/sangue , Glutationa/sangue , Humanos , Peroxidação de Lipídeos/efeitos dos fármacos , Peróxidos Lipídicos/sangue , Estudos Prospectivos , Distribuição Aleatória , Fatores de Tempo , Levantamento de Peso
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA